Business
Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes
The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.
About this update from Biogen Inc.
[{"type":"text","content":"AUSTIN, Texas and TOKYO, Oct. 7, 2025 /PRNewswire/ -- The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.","length":548,"tagName":"p"},{"type":"image","alt":"DataM Intelligence 4 Market Research LLP Logo","displaySize":"","headline":null,"caption":"DataM Intelligence 4 Market Research LLP Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nG.P2cl8s5cqOxbtvsLrwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd","width":400,"height":400}}},{"type":"text","content":"Neuromuscular diseases-including amyotrophic lateral sclerosis (ALS), muscular dystrophies, spinal muscular atrophy (SMA), and myasthenia gravis-impact millions globally, with limited curative options historically. Advances in genomic medicine, targeted biologics, and digital diagnostics are reshaping the treatment landscape.","length":327,"tagName":"p"},{"type":"text","content":"Global leaders such as Novartis, Biogen, AbbVie, AstraZeneca, Argenx, Takeda, and Sarepta Therapeutics are pioneering next-generation therapeutics. With strong regulatory backing, particularly from the U.S. FDA and Japan's PMDA, and rising investment in rare disease research, the neuromuscular therapeutics space is poised for sustained double-digit growth.","length":362,"tagName":"p"},{"type":"text","content":"Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/neuromuscular-disease-therapeutics-market ","length":128,"tagName":"p"},{"type":"text","content":"Browse in-depth TOC on "Neuromuscular Disease Therapeutics Market" 73 – Tables76 – Figures196 – Pages","length":115,"tagName":"p"},{"type":"text","content":"Market Segmentation Analysis","length":28,"tagName":"...